,懂了$Tekmira Pharmaceuticals Corp(TKMR)$//@投资女学徒:回复@william_hsu:再选一个靠谱的股票 再来研究 不要连初审都过不了的
查看全文
Wiliamhsu2015-07-19 12:31
回复@Potatomatobacco: 以前说消费带动投资和产业升级不理解,刚刚想到,当越来越多的中国人开始消费苹果、特斯拉、SPACE X、外骨骼、基因医药时,中国自然就开始产业升级了。有些消费推动产业升级的正反馈,有些不是。
当中国人象美国人一样开始消费苹果、特斯拉、外骨骼、光伏电力时,中国会...查看全文
美股基金策略2015-07-07 21:40
$Sangamo Biosciences (SGMO)$ $TG THERAPEUTICS INC(TGTX)$ $Ardelyx(ARDX)$ $Dyax(DYAX)$ $爱克莱恩(ACHN)$ $Tekmira Pharmaceuticals Corp(TKMR)$ $Coherus BioSciences(CHRS)$
Peter Kolchinsky,美国RA医疗资本创始人,专注于生物制药领域二级市场和一级市场投资。在4岁的时候,Kolchins...查看全文
$Tekmira Pharmaceuticals Corp(TKMR)$ CT ORDER - Confidential treatment order Filed: 2017-01-06 AccNo: 9999999997-17-000046 Size: 11 KB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2016-12-23 AccNo: 0001193125-16-802728 Size: 374 KB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2016-12-22 AccNo: 0000912282-16-000926 Size: 1 MB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ 8-K - Current report Filed: 2016-12-12 AccNo: 0001171843-16-013604 Size: 28 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ CORRESP [Cover] - Correspondence Filed: 2016-10-17 AccNo: 0000912282-16-000877 Size: 200 KB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-11-10 AccNo: 0000000000-16-100421 Size: 36 KB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ 8-K - Current report Filed: 2016-11-14 AccNo: 0001171843-16-013217 Size: 16 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-03 AccNo: 0001628280-16-020766 Size: 6 MB 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ 8-K - Current report Filed: 2016-11-03 AccNo: 0001171843-16-012925 Size: 73 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Tekmira Pharmaceuticals Corp(TKMR)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-10-19 AccNo: 0001104659-16-150928 Size: 57 KB 网页链接